Suchergebnisse - (Person:"Barreiro, Pablo")

PubPharm (43)

1

Is Ribavirin Teratogenic in Humans? No Evidence So Far

enthalten in: Drug safety | 2017

von Soriano, V. | Barreiro, P.

CommentOn: Drug Saf. 2017 Dec;40(12):1205-1218. - PMID 28689333

2

Long-term survival and liver-related events after pegylated interferon/ribavirin therapy in HIV-infected patients with chronic hepatitis C

enthalten in: Antiviral therapy | 2015

von Labarga, P. | Fernández-Montero, J. | de Mendoza, C. | +2

3

Sustained virological response in HIV/HCV co-infected patients treated with pegylated interferon/ribavirin can be predicted from the overall rate of viral load decline over the first 4 weeks of therapy

enthalten in: The Journal of infection | 2014

von Rivero-Juarez, A. | Neukam, K. | Labarga, P. | +7

4

Liver fibrosis progression in HIV-HCV-coinfected patients treated with distinct antiretroviral drugs and impact of pegylated interferon/ribavirin therapy

enthalten in: Antiviral therapy | 2014

von Fernández-Montero, J. | Barreiro, P. | Vispo, E. | +5

5

Variations at multiple genes improve interleukin 28B genotype predictive capacity for response to therapy against hepatitis C infection

enthalten in: AIDS (London, England) | 2013

von Neukam, K. | Caruz, A. | Rivero-Juárez, A. | +10

6

Chronic hepatitis E in HIV patients : rapid progression to cirrhosis and response to oral ribavirin

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2013

von Neukam, K. | Barreiro, P. | Macías, J. | +7

7

Pegylated interferon plus ribavirin is suboptimal in IL28B CC carriers without rapid response

enthalten in: The Journal of infection | 2013

von Neukam, K. | Barreiro, P. | Rivero-Juárez, A. | +7

8

Very late relapse after discontinuation of antiviral therapy for chronic hepatitis C

enthalten in: Antiviral therapy | 2013

von Soriano, V. | Vispo, E. | de Mendoza, C. | +6

9

Pharmacokinetics of new oral hepatitis C antiviral drugs

enthalten in: Expert opinion on drug metabolism & toxicology | 2013

von Vispo, E. | Barreiro, P. | Soriano, V.

10

Different impact of IL28B polymorphisms on response to peginterferon-α plus ribavirin in HIV-positive patients infected with HCV subtypes 1a or 1b

enthalten in: Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology | 2012

von Vispo, E. | Rallon, N. | Labarga, P. | +3

1
2
3
4
5
Nächster »
[5]